Glee Biotech Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 2020.
2020 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Glee Biotech Limited

Glee Biotech Limited, a active public limited company, was established on 03 March 2020 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33100DL2020PLC362536. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Kiran Bhatia (Director), Vikas Khatri (Director), Rachna Bhatia (Director). Past directors included Kiran Bhatia, Vikas Khatri, Anil Kumar. It holds ₹6.53 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 301-302, Block & Pocket B-4 Sector-8, Rohini, New Delhi, Delhi, 110085.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100DL2020PLC362536

  • Registration Number

    362536

  • Incorporation Date

    03 March 2020

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 5 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.53 Cr
  • Revenue Growth **** 9.73%
  • Profit Growth **** 64.89%
  • Ebitda **** 86.57%
  • Net Worth 106.92%
  • Total Assets **** 100.43%
Company report

Glee Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Glee Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Glee Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Kiran Bhatia Director 08 Dec 2020 Current
Vikas Khatri Director - Current
Rachna Bhatia Director 03 Mar 2020 Current
Raghav Bhatia Director 03 Mar 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Director 09 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glee Biotech.

Glee Biotech Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.73% increase. The company also saw a substantial improvement in profitability, with a 64.89% increase in profit. The company's net worth Soared by an impressive increase of 106.92%.

Glee Biotech revenue growth over time
Glee Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.73%
*******
*******
*******
*******
Revenue from Operations
*******
 9.71%
*******
*******
*******
*******
Total Assets
*******
 100.43%
*******
*******
*******
*******
Profit or Loss
*******
 64.89%
*******
*******
*******
*******
Net Worth
*******
 106.92%
*******
*******
*******
*******
EBITDA
*******
 86.57%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glee Biotech?

In 2023, Glee Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹65,287,822.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 6.01 Cr
  • Others : 0.52 Cr
Latest Charge Details
Date Lender Amount Status
17 Dec 2025 Others ₹5.20 M Open
25 Sep 2025 Hdfc Bank Limited ₹1.36 M Open
06 Sep 2025 Hdfc Bank Limited ₹1.71 M Open
28 Aug 2025 Hdfc Bank Limited ₹0.66 M Open
02 Aug 2025 Hdfc Bank Limited ₹1.95 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Glee Biotech?

Unlock and access historical data on people associated with Glee Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glee Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glee Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glee Biotech
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others amounted to Rs. 5.20 M with Charge ID 101215751 was registered on 17 Dec 2025. was documented.

  • Annual General Meeting

    The activity Glee Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 1.36 M with Charge ID 101168055 was registered on 25 Sep 2025. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.71 M with Charge ID 101160703 was registered on 06 Sep 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.66 M with Charge ID 101156532 was registered on 28 Aug 2025. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 1.95 M with Charge ID 101143853 was registered on 02 Aug 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Glee Biotech Limited?

The CIN of Glee Biotech Limited is U33100DL2020PLC362536.

Where is Glee Biotech Limited headquartered?

Glee Biotech Limited is headquartered at 301-302, Block & Pocket B-4 Sector-8, Rohini, New Delhi, Delhi, 110085.

When was Glee Biotech Limited incorporated?

Glee Biotech Limited was incorporated on 03 March 2020.

Who are the current directors of Glee Biotech Limited?

The current directors of Glee Biotech Limited are

What is the primary industry of Glee Biotech Limited?

The primary industry of Glee Biotech Limited is Trade.

Is Glee Biotech Limited a listed company?

Glee Biotech Limited is unlisted.

What is the capital structure of Glee Biotech Limited?

The authorized capital of Glee Biotech Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Glee Biotech Limited?

The compliance status of Glee Biotech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available